63 results
S-3ASR
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Automatic shelf registration
4:05pm
Statement.
As counsel for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Registration
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
, before deducting any offering-related expenses. The private placement is expected to close on or about March 1, 2024, subject to the satisfaction … , including statements regarding Crinetics’ expectations of market conditions and the satisfaction of customary closing conditions related to the private
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and sale of the Shares to the Purchasers by the Company (the “Closing”) will occur, subject to the satisfaction or waiver of the conditions set forth … to the satisfaction of certain conditions (if applicable), including, among other things, the existence of a public market for the securities
S-8
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
28 Feb 24
Registration of securities for employees
6:04pm
for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records
8-K
EX-99.2
q3f334z07l2okix
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
hwdukyi wtvqnh5btq3
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-1.1
o8lnf2
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-99.1
c8ivfvsie x214pj
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
424B5
q1inf40d47174
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
kttn5j7vdapqcj482ovc
11 Sep 23
Prospectus supplement for primary offering
4:09pm
8-K
i4re5f5lqls7hpzpb
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
ebftggpowtw qcz68
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-99.1
1wttua8uw8wi12 olp
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-10.1
4yvyysj f9u4emn6
23 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
i10k8 d64mi0
8 Nov 21
Other Events
8:53am